EXam 3 Men's Health Flashcards
BPH:Clinical Presentation
Decreased urinary flow
Hesitancy
Post-void residual
Nocturia
Urgency
Dysuria
Urge and overflow incontinence
BPH:Exam Findings
Enlarged prostate (larger than walnut size)
Gross Hematuria
Distended bladder
* Increased post-void residual
BPH:Diagnostics
Elevated pH
Elevated serum creatinine
Elevated PSA-less than 10ng/mL
Urine culture- sometime positive for bacteria
AUASI questionnaire
* Mild -> 0-7
* Moderate -> 8-19
* severe case -> 20 or greater
BPH:Management
Mild-Moderate (0-7)
* Watchful waiting
Moderate (8-19)
* Initiate medication
High (=>20)
* Vigorous treatment
* Refer to urologist
BPH:Management Medication
- Selective alpha1-adrenergic agonists
- Relaxes bladder neck (titrate dose)
- Prazosin (Minipress) 1 to 5 mg bid
- Terazosin (Hytrin) 1 to 10 mg qd
- Doxazosin (Cardura) 1 to 8 mg qd
- Silodosin (Rapaflo) 4-8 mg daily
o Subtype alpha1-adrenergic blockers (no titration)
Relaxes smooth muscles in the bladder neck and prostate
Eases pressure on the urethra and bladder - Tamsulosin (Flomax) 0.4 or 0.8 mg qd
- Alfuzosin (UroXatral) 10 to 15 mg qd (immediately after the same meal each day)
o 5-alpha-reductase inhibitors
Reduce size (but may take 6 months) - Finasteride (Proscar)
- Dutasteride (Avodart)
o Combo 5 alpha reductase inhibitor with alpha blocker
Finasteride or Dutasteride with an alpha blocker
Tamsulosin/dutasteride (combodart)
Erectile Dysfunction: Classification and clinical symptoms
Inability to maintain erection
Lack of sexual desire
* Classification:
* Mild: failed erection 2/10 attempts
* Moderate: in between
* Severe: failed erection all attempts
Erectile Dysfunction: Evaluation
Detailed medical, sexual, and social hx.
Erectile Dysfunction: Diagnostic work up
fasting glucose, lipids, TSH
Testosterone level (normal level is <300; best assessed between 0700-1000 am; begins to decline after age 30), PSA, CBC, BMP
Erectile Dysfunction: Screening tools
- International Index of Erectile Function (IIEF)
- NPTR- during sleep
- Color Doppler sonography- measures vascular causes
Erectile Dysfunction: Management
Lifestyle medications: 25% of cases are due to ETOH use, smoking, recreational drugs.
Erectile Dysfunction: Management
Medications: Hormone replacement Therapy (Testosterone)
* Testosterone injections range from 100 to 200 mg every two weeks to 50 to 100 mg weekly
* Phosphodiesterase-5 inhibitors — For first-line therapy of ED, we recommend the PDE5 inhibitors because of their efficacy, ease of use, and favorable side-effect profile.
Sildenafil, vardenafil, tadalafil, and the newest option, avanafil, appear to be equally effective, but tadalafil has a longer duration of action and avanafil has a more rapid onset
Erectile Dysfunction: Patient Education
Patient education: management of chronic conditions-> DM, HTN, Stress, safety if using testosterone replacement formulations (dangerous if transferred to partner)
Prostatitis: Risk Factors
Age (>50)
History of Prostatic Calculi
Previous UTI
Prostatitis: Clinical Presentation
Tenesmus
Pain in the lower back or with urination
Persistent desire to empty bowel or bladder
Obstructive symptoms- weak urine stream, incomplete bladder emptying, terminal dribbling
Prostatitis: Physical Exam
Prostate exam: with care! Vigorous stimulation of the prostate can result in septicemia.
In a patient with acute bacterial prostatitis, the prostate will often be tender, enlarged, or boggy.
If chronic the exam may reveal a tender prostate but it may not be swollen or boggy.
GU exam:
* acute onset of irritative (e.g., dysuria, urinary frequency, urinary urgency) or obstructive (e.g., hesitancy, incomplete voiding, straining to urinate, weak stream) voiding symptoms.
* Patients may report suprapubic, rectal, or perineal pain.
* Painful ejaculation, hematospermia, and painful defecation may be present
* Systemic symptoms, such as fever, chills, nausea, emesis, and malaise, commonly occur, and their presence should prompt physicians to determine if patients meet clinical criteria for sepsis.